Skip to main content

Amesite Inc.

corporate_fare Company Profile

Amesite Inc.

AMST·NASDAQ·Technology·CIK 0001807166

Amesite Inc. is a technology company that builds and commercializes AI-powered solutions for enterprises and professionals, with a particular focus on the post-acute healthcare market. In fiscal 2026, the company launched a census-based Enterprise tier featuring EMR compatibility, automated interdisciplinary team reporting, and configurable documentation. During the same fiscal year, Amesite introduced the AI-native NurseMagic™ EMR capability and secured its largest enterprise deployment to date, serving an approximately 2,700-patient census. Amesite operates through two product lines: NurseMagic™ and LynkMagic™. NurseMagic™ solutions include a B2B enterprise application and a B2C solution for individual healthcare professionals. LynkMagic™ provides enterprise AI solutions for healthcare and related organizations. The company's products support documentation, workflow, compliance, and oversight, and are designed to improve operational quality and efficiency. The B2C NurseMagic™ app connects directly with working nurses and caregivers, offering tools to reduce documentation time, simplify communication, and support daily workflow. The B2B NurseMagic™ solution serves healthcare businesses, including home health, skilled nursing, hospice, and non-clinical segments. Enterprises adopting NurseMagic™ aim to improve workflow efficiency, data security, and regulatory compliance. Amesite's offerings are engineered for fast, secure deployment and measurable value in demanding business environments.

Amesite Inc. (NASDAQ:AMST) is a publicly traded company in the Technology sector. Wiseek has independently scored 23 items for AMST at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 18 rated 8 or above. Recent SEC coverage for AMST spans 10-Q, 8-K, DEF 14A, PRE 14A.

Recent high-impact activity:

  • Amesite Q1 Loss Widens to $774K; Going Concern Doubt Reaffirmed as Equity Falls Below Nasdaq Minimum
  • Amesite Receives Nasdaq Bid-Price Deficiency Notice, Has 180 Days to Reach $1.00
  • Amesite Sets December 10 Vote on 1-for-250 Reverse Split and $25M Discounted Offering
  • Amesite Seeks Approval for 1-for-250 Reverse Split and $25M Discounted Offering
  • Amesite 10-K: Going Concern Warning as Cash Dwindles to $2.4M

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
364.78K
Net Income
-3.1M
Diluted EPS
-0.63
Op. Cash Flow
-2.15M
Free Cash Flow
-2.15M
Operating Income
-3.14M
Cash & Equivalents
2.3M
Debt / Equity
0.00×
Net Margin
-8.49×
Shares Outstanding
6.55M sh
Source: 10-K · filed 2026-09-23 · accession 0001213900-26-102676

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 28,270 shares in AMST as of the October 30, 2026 settlement, a 27.3% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 21.9% of AMST volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)28,270 shares as of October 30, 2026
Change vs prior period▼ 27.3%
Days to cover1.00 at avg daily volume of 39,945
Daily short volume (FINRA facilities)21.9% of 15,332 shares on November 20, 2026
5-day average short volume34.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

High risk

Filing-implied dilution signals for AMST, detected from its recent SEC filings · based on capital-structure filings through 2026-07-17.

1 recent capital raiseATM program1 shelf registration

ATM Program Established · Potential Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with A →
$0.5527 +8.37% today
52-week range · as of 2026-11-13 $0.46 – $2.9
Market cap
$3.34M
Volume
31.9K (0.0× avg)
3-mo avg 658K
Live data · 2026-11-22 10:01 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AMST - Latest Insights

AMST
Nov 13, 2026, 4:02 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.475
Real-time Price: $0.552693 info
Change: +$0.077693 (+16%) info
Market Cap: $3.34M info
AMST
Nov 13, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.475
Real-time Price: $0.552693 info
Change: +$0.077693 (+16%) info
Market Cap: $3.34M info
AMST
Oct 14, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.8425
Real-time Price: $0.552693 info
Change: -$0.289807 (-34%) info
Market Cap: $3.34M info
AMST
Oct 02, 2026, 4:30 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.940
Real-time Price: $0.552693 info
Change: -$0.387307 (-41%) info
Market Cap: $3.34M info
AMST
Sep 23, 2026, 4:58 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.04
Real-time Price: $0.552693 info
Change: -$0.487307 (-47%) info
Market Cap: $3.34M info
AMST
Jun 03, 2026, 5:29 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $1.31
Real-time Price: $0.552693 info
Change: -$0.757307 (-58%) info
Market Cap: $3.34M info
AMST
Jun 03, 2026, 5:29 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $1.31
Real-time Price: $0.552693 info
Change: -$0.757307 (-58%) info
Market Cap: $3.34M info
AMST
May 19, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.20
Real-time Price: $0.552693 info
Change: -$1.65 (-75%) info
Market Cap: $3.34M info
AMST
May 19, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.50
Real-time Price: $0.552693 info
Change: -$0.947307 (-63%) info
Market Cap: $3.34M info
AMST
May 18, 2026, 4:51 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.7872
Real-time Price: $0.552693 info
Change: -$0.234507 (-30%) info
Market Cap: $3.34M info
AMST
May 18, 2026, 4:46 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.7872
Real-time Price: $0.552693 info
Change: -$0.234507 (-30%) info
Market Cap: $3.34M info
AMST
May 18, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $0.7861
Real-time Price: $0.552693 info
Change: -$0.233407 (-30%) info
Market Cap: $3.34M info
AMST
May 18, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $0.7861
Real-time Price: $0.552693 info
Change: -$0.233407 (-30%) info
Market Cap: $3.34M info
AMST
May 12, 2026, 5:24 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $0.8113
Real-time Price: $0.552693 info
Change: -$0.258607 (-32%) info
Market Cap: $3.34M info
AMST
Apr 28, 2026, 4:57 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.950
Real-time Price: $0.552693 info
Change: -$0.397307 (-42%) info
Market Cap: $3.34M info
AMST
Apr 28, 2026, 9:47 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.920
Real-time Price: $0.552693 info
Change: -$0.367307 (-40%) info
Market Cap: $3.34M info
AMST
Apr 28, 2026, 9:43 AM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $0.910
Real-time Price: $0.552693 info
Change: -$0.357307 (-39%) info
Market Cap: $3.34M info
AMST
Apr 28, 2026, 8:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.16
Real-time Price: $0.552693 info
Change: -$0.607607 (-52%) info
Market Cap: $3.34M info
AMST
Apr 27, 2026, 12:25 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.12
Real-time Price: $0.552693 info
Change: -$0.562307 (-50%) info
Market Cap: $3.34M info
AMST
Apr 23, 2026, 1:04 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $1.10
Real-time Price: $0.552693 info
Change: -$0.547307 (-50%) info
Market Cap: $3.34M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets